Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experience
ARDs do not seem to represent an absolute or relative contraindication in BC RT in terms of acute and late cutaneous toxicity. Hypofractionated schedule showed less toxicities in both group and, particularly, in ARDs group.
Authors
- Giulia De Pasquale (ORCID: https://orcid.org/0000-0001-9983-7086)
- Andrea D’Aviero (ORCID: https://orcid.org/0000-0002-9194-620X)
- Domenico Genovesi (ORCID: https://orcid.org/0000-0002-4099-0534)
- Rosario Bonelli
- Marta Di Nicola (ORCID: https://orcid.org/0000-0003-1748-1931)
- M. Nuzzo (ORCID: https://orcid.org/0000-0002-8723-9123)
- Annamaria Porreca (ORCID: https://orcid.org/0000-0003-3278-1561)
- Consuelo Rosa (ORCID: https://orcid.org/0000-0002-9680-776X)
- Annamaria Vinciguerra
- Marco Lucarelli
- Valeria Donatiello
Institutions
- University of Chieti-Pescara (IT)
- Ospedale SS. Annunziata (IT)
Publication Details
- Journal
- Breast Cancer
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1007/s12282-025-01791-7
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00